These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 16217761)

  • 1. Immune stimulatory effects of CD70 override CD70-mediated immune cell apoptosis in rodent glioma models and confer long-lasting antiglioma immunity in vivo.
    Aulwurm S; Wischhusen J; Friese M; Borst J; Weller M
    Int J Cancer; 2006 Apr; 118(7):1728-35. PubMed ID: 16217761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of CD70-mediated apoptosis of immune effector cells as a novel immune escape pathway of human glioblastoma.
    Wischhusen J; Jung G; Radovanovic I; Beier C; Steinbach JP; Rimner A; Huang H; Schulz JB; Ohgaki H; Aguzzi A; Rammensee HG; Weller M
    Cancer Res; 2002 May; 62(9):2592-9. PubMed ID: 11980654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble CD70: a novel immunotherapeutic agent for experimental glioblastoma.
    Miller J; Eisele G; Tabatabai G; Aulwurm S; von Kürthy G; Stitz L; Roth P; Weller M
    J Neurosurg; 2010 Aug; 113(2):280-5. PubMed ID: 19961309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coexpression of CD40L and CD70 by semiallogenic tumor cells induces anti-tumor immunity.
    Cormary C; Hiver E; Mariamé B; Favre G; Tilkin-Mariamé AF
    Cancer Gene Ther; 2005 Dec; 12(12):963-72. PubMed ID: 15956983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MICA/NKG2D-mediated immunogene therapy of experimental gliomas.
    Friese MA; Platten M; Lutz SZ; Naumann U; Aulwurm S; Bischof F; Bühring HJ; Dichgans J; Rammensee HG; Steinle A; Weller M
    Cancer Res; 2003 Dec; 63(24):8996-9006. PubMed ID: 14695218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of tumor-specific T cell memory by NK cell-mediated tumor rejection.
    Kelly JM; Darcy PK; Markby JL; Godfrey DI; Takeda K; Yagita H; Smyth MJ
    Nat Immunol; 2002 Jan; 3(1):83-90. PubMed ID: 11743585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glioblastomas induce T-lymphocyte death by two distinct pathways involving gangliosides and CD70.
    Chahlavi A; Rayman P; Richmond AL; Biswas K; Zhang R; Vogelbaum M; Tannenbaum C; Barnett G; Finke JH
    Cancer Res; 2005 Jun; 65(12):5428-38. PubMed ID: 15958592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Virus-induced polyclonal B cell activation improves protective CTL memory via retained CD27 expression on memory CTL.
    Matter M; Mumprecht S; Pinschewer DD; Pavelic V; Yagita H; Krautwald S; Borst J; Ochsenbein AF
    Eur J Immunol; 2005 Nov; 35(11):3229-39. PubMed ID: 16231287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuous CD27 triggering in vivo strongly reduces NK cell numbers.
    De Colvenaer V; Taveirne S; Hamann J; de Bruin AM; De Smedt M; Taghon T; Vandekerckhove B; Plum J; van Lier R; Leclercq G
    Eur J Immunol; 2010 Apr; 40(4):1107-17. PubMed ID: 20140903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphocyte activation antigen CD70 expressed by renal cell carcinoma is a potential therapeutic target for anti-CD70 antibody-drug conjugates.
    Law CL; Gordon KA; Toki BE; Yamane AK; Hering MA; Cerveny CG; Petroziello JM; Ryan MC; Smith L; Simon R; Sauter G; Oflazoglu E; Doronina SO; Meyer DL; Francisco JA; Carter P; Senter PD; Copland JA; Wood CG; Wahl AF
    Cancer Res; 2006 Feb; 66(4):2328-37. PubMed ID: 16489038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SD-208, a novel transforming growth factor beta receptor I kinase inhibitor, inhibits growth and invasiveness and enhances immunogenicity of murine and human glioma cells in vitro and in vivo.
    Uhl M; Aulwurm S; Wischhusen J; Weiler M; Ma JY; Almirez R; Mangadu R; Liu YW; Platten M; Herrlinger U; Murphy A; Wong DH; Wick W; Higgins LS; Weller M
    Cancer Res; 2004 Nov; 64(21):7954-61. PubMed ID: 15520202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endogenous expression of transforming growth factor beta1 inhibits growth and tumorigenicity and enhances Fas-mediated apoptosis in a murine high-grade glioma model.
    Ashley DM; Kong FM; Bigner DD; Hale LP
    Cancer Res; 1998 Jan; 58(2):302-9. PubMed ID: 9443409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD70, a novel target of CAR T-cell therapy for gliomas.
    Jin L; Ge H; Long Y; Yang C; Chang YE; Mu L; Sayour EJ; De Leon G; Wang QJ; Yang JC; Kubilis PS; Bao H; Xia S; Lu D; Kong Y; Hu L; Shang Y; Jiang C; Nie J; Li S; Gu Y; Sun J; Mitchell DA; Lin Z; Huang J
    Neuro Oncol; 2018 Jan; 20(1):55-65. PubMed ID: 28651374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of T-cell antitumor immunity and protection against tumor growth by secretion of soluble human CD70 molecules.
    Cormary C; Gonzalez R; Faye JC; Favre G; Tilkin-Mariamé AF
    Cancer Gene Ther; 2004 Jul; 11(7):497-507. PubMed ID: 15153937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reciprocal expression of CD70 and of its receptor, CD27, in human long term-activated T and natural killer (NK) cells: inverse regulation by cytokines and role in induction of cytotoxicity.
    Orengo AM; Cantoni C; Neglia F; Biassoni R; Ferrini S
    Clin Exp Immunol; 1997 Mar; 107(3):608-13. PubMed ID: 9067541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-tumor immunity elicited by a recombinant vaccinia virus expressing CD70 (CD27L).
    Lorenz MG; Kantor JA; Schlom J; Hodge JW
    Hum Gene Ther; 1999 May; 10(7):1095-103. PubMed ID: 10340542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD27 and CD70 in T cell and B cell activation.
    Borst J; Hendriks J; Xiao Y
    Curr Opin Immunol; 2005 Jun; 17(3):275-81. PubMed ID: 15886117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD70 reverse signaling enhances NK cell function and immunosurveillance in CD27-expressing B-cell malignancies.
    Al Sayed MF; Ruckstuhl CA; Hilmenyuk T; Claus C; Bourquin JP; Bornhauser BC; Radpour R; Riether C; Ochsenbein AF
    Blood; 2017 Jul; 130(3):297-309. PubMed ID: 28495792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RNA interference targeting transforming growth factor-beta enhances NKG2D-mediated antiglioma immune response, inhibits glioma cell migration and invasiveness, and abrogates tumorigenicity in vivo.
    Friese MA; Wischhusen J; Wick W; Weiler M; Eisele G; Steinle A; Weller M
    Cancer Res; 2004 Oct; 64(20):7596-603. PubMed ID: 15492287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation by IL-2 of CD70 and CD27 expression on CD8+ T cells: importance for the therapeutic effectiveness of cell transfer immunotherapy.
    Huang J; Kerstann KW; Ahmadzadeh M; Li YF; El-Gamil M; Rosenberg SA; Robbins PF
    J Immunol; 2006 Jun; 176(12):7726-35. PubMed ID: 16751420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.